This year, a new test for the early detection of endometrial and ovarian cancer wins the 2018 Science Discovery People’s Choice Award of the Year. The test named “DOvEEgene,” was selected by almost a third of all the Québec Science magazine readers.
Developed by a team from the Research Institute of the McGill University Health Centre (RI-MUHC), led by Dr. Lucy Gilbert, and Dr. Kris Jardon, in collaboration with researchers at Johns Hopkins University School of Medicine, the test is capable of detecting more than 70 per cent of early ovarian and endometrial cancers with a high accuracy rate.
Together, uterine and ovarian cancers, which are usually difficult to identify, are the third leading cause of cancer deaths among women.
Source:
Knowing what to look for is important, so people can get support to help them…
Image: Laura James With 10,000 healthcare workers already off the job amid the sixth wave of pandemic…
Photo: Anete Lusina If your employer invites you to attend a meeting, you MUST ask…
The C.D.C. also affirmed there is no need to quarantine at home following high-risk exposures…
Hospital executives who have hired Litvak describe him as a genius and a pioneer in…
Photo cottonbro / Pexels Many people focus on worst-case scenarios in the days following the…
This website uses cookies.